Search Results - "Berton-Rigaud, D."

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Authors: Montassier T Laas E Hotton J et al.

Source: Gynecologic oncology [Gynecol Oncol] 2026 Jun 26; Vol. 211, pp. 59-66. Date of Electronic Publication: 2026 Jun 26.

Publication Type: Journal Article

Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Immunotherapy in Endometrial Cancer: Molecular Classification, Clinical Evidence, and Therapeutic Implications: A Narrative Review.

Authors: Padilla-Iserte, Pablo Cabrera, Silvia Gatius Calderó, Sonia et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1709. 18p.

Endometriosis‐Associated Ovarian Carcinosarcoma Featuring Well‐Differentiated Adenocarcinoma and Fetal Rhabdomyoma‐Like Mesenchymal Components: An Unusual Case Report—With Molecular Analysis.

Authors: Narusawa, Yuri Asaka, Shiho Muramoto, Tsutomu et al.

Source: Case Reports in Pathology. 5/27/2026, Vol. 2026, p1-8. 8p.

Association of a CHEK2 somatic variant with tumor microenvironment calprotectin expression predicts platinum resistance in a small cohort of ovarian carcinoma.

Authors: de Amorim, Izabela Ferreira Gontijo Melo, Carolina Pereira de Souza Pereira, Ramon de Alencar et al.

Source: PLoS ONE. 3/27/2025, Vol. 20 Issue 3, p1-16. 16p.

PARP Inhibitors and the Risk of Serum Creatinine Elevation in Ovarian Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors: Gąsowska-Bodnar, Agnieszka Gąsowska-Bajger, Beata Żołnierek, Aleksandra et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1226. 11p.

A Meta-Analysis on the Long-Term Impact of Cytoreductive Surgery Plus HIPEC for Ovarian Cancer with Peritoneal Metastasis: Are We on the Right Path?

Authors: Brebu, Dan Șelaru, Mircea Faur, Ionut Flaviu et al.

Source: Life (2075-1729). Feb2026, Vol. 16 Issue 2, p335. 15p.

Chemotherapy and Other Systemic Drugs Used to Treat Gynecologic Carcinosarcomas (GCSs): A Retrospective Analysis from Hospital Clínico San Carlos (HCSC), An Academic Referral Centre for Rare Gynecological Malignancies in Madrid, Spain.

Authors: Marquina, Gloria Gonzalez-Diez, Beatriz Coronado, Pluvio J. et al.

Source: Cancers. Oct2025, Vol. 17 Issue 20, p3359. 14p.

Efficacy and safety of secondary cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in platinum-sensitive recurrent ovarian cancer: a systematic review and meta-analysis.

Authors: Liu, Han-Yan Tian, Lin-Huan Huang, Ge et al.

Source: World Journal of Surgical Oncology. 11/10/2025, Vol. 23 Issue 1, p1-11. 11p.

Prognostic Impact of Pre-Treatment Modified Glasgow Prognostic Score (mGPS) on Survival in Patients with Advanced-Stage Ovarian Cancer.

Authors: Kus, Fatih Sirvan, Firat Yildirim, Hasan Cagri et al.

Source: Journal of Clinical Medicine. Jun2025, Vol. 14 Issue 12, p4239. 7p.

A Narrative Approach to Mismatch Repair-Deficient Endometrial Cancer.

Authors: Barberis, Massimo Zhan, Yinxiu

Source: Journal of Molecular Pathology. Jun2026, Vol. 7 Issue 2, p17. 18p.

Acetyl-l-Carnitine in the Treatment of Peripheral Neuropathies: A Narrative Review.

Authors: Fornasari, Diego Maria Michele¹ (AUTHOR) diego.fornasari@unimi.it

Source: Pain & Therapy. Jun2026, Vol. 15 Issue 3, p601-622. 22p.

Recurrent Distant Metastatic Endometrial Cancer Treated with Immunotherapy with Pembrolizumab: A Case Report and Literature Review.

Authors: Leung, Oi-Yin Cheng, Chiu-Hsuan Ding, Dah-Ching

Source: Diagnostics (2075-4418). Jun2026, Vol. 16 Issue 11, p1703. 18p.

子宫内膜癌的免疫微环境及免疫治疗研究进展.

Alternate Title: Research progress on immune microenvironment and immunotherapy of endometrial cancer.

Authors: 陈毓涵 艾志宏

Source: Journal of Shanghai Jiaotong University (Medical Science). 2026, Vol. 46 Issue 5, p656-664. 9p.

Predictive Biomarkers for Immunotherapy in Endometrial Carcinoma.

Authors: Pizzimenti, Cristina Fiorentino, Vincenzo Pepe, Ludovica et al.

Source: Cancers. Aug2025, Vol. 17 Issue 15, p2420. 20p.

Prognostic impact of suspicious extraabdominal lymph nodes on patient survival in advanced ovarian cancer.

Authors: Park, Kena Kwon, Ji Young Song, Jeong Min et al.

Source: PLoS ONE. 5/28/2024, Vol. 19 Issue 5, p1-13. 13p.

Clinicopathological Predictors of Recurrence in Uterine Sarcomas—A Narrative Review.

Authors: Kontomanolis, Emmanuel N. Sapantzoglou, Ioakeim Nikolettos, Konstantinos et al.

Source: Journal of Clinical Medicine. Jul2025, Vol. 14 Issue 14, p4883. 26p.

Pyroptosis, ferroptosis, and autophagy in immune therapy: perspective for immunotherapy of endometrial cancer.

Authors: Ren, Liangxin Yu, Qixia Pan, Yao et al.

Source: Molecular & Cellular Toxicology. Jun2025, Vol. 21 Issue 3, p443-454. 12p.

An Updated Meta-Analysis on Long-Term Outcomes Following Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer.

Authors: El Kassis, Nadine Jerbaka, Myriam Abou Chakra, Rime et al.

Source: Cancers. May2025, Vol. 17 Issue 9, p1569. 16p.

Efficacy and safety of immune checkpoint inhibitors for advanced or recurrent endometrial cancer: a systematic review and network meta-analysis.

Authors: Huang, Danxue Li, Su Bai, Yang et al.

Source: BMC Cancer. 10/22/2024, Vol. 24 Issue 1, p1-9. 9p.

Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline BRCA2 Pathogenic Variant: Case Report.

Authors: Mendes Gomes, Luciana Beatriz Lazari Sandoval, Renata Bragança Xavier, Camila et al.

Source: Case Reports in Oncology. 2024, Vol. 17 Issue 1, p1-9. 9p.